Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,550 JPY | +1.71% | +3.61% | +8.94% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.94% | 882M | |
-2.48% | 88.14B | |
+3.29% | 40.44B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.41% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Jefferies Upgrades Sosei to Buy From Hold, Adjusts Price Target to 1,700 Yen From 1,600 Yen